Victor Bulto, president of Novartis US, said in an interview with Fierce Pharma Marketing. The answer was “pretty clear,” he said: Address the breast cancer diagnosis gap. “Right now ...

"PBM reform is top of mind with legislators," Victor Bulto, president of Novartis' U.S. operations said in an interview this week during the JP Morgan Healthcare Conference in San Francisco.